Researcher
Hendrik Jan Thibaut
- Disciplines:Microbiology, Systems biology, Laboratory medicine
Affiliations
- Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From1 Oct 2006 → Today
Projects
1 - 1 of 1
- Uncovering kinase inhibitor resistance mechanisms via CRISPR-based gain-of-function mutagenesis.From12 Jul 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
41 - 50 of 64
- Antiviral activity of broad-spectrum and enterovirus-specific inhibitors against clinical isolates of enterovirus D68(2015)
Authors: Liang Sun, Mathy Froeyen, Hendrik Jan Thibaut, Jim Baggen, Pieter Leyssen, Johan Neyts, Leen Delang
Pages: 7782 - 5 - The microRNA-221/-222 cluster balances the antiviral and inflammatory response in viral myocarditis(2015)
Authors: Ward Heggermont, Anna-Pia Papageorgiou, Aloys Tijsma, Paolo Carai, Hendrik Jan Thibaut, Johan Neyts, Stephane Heymans
Pages: 2909 - 19 - Sialic acid-dependent cell entry of human enterovirus D68(2015)
Authors: Jim Baggen, Hendrik Jan Thibaut
- Broad-range inhibition of enterovirus replication by OSW-1, a natural compound targeting OSBP(2015)
Authors: Lucian Albulescu, Jeroen R P M Strating, Hendrik Jan Thibaut, Lonneke van der Linden, Matthew D Shair, Johan Neyts, Frank J M van Kuppeveld
Pages: 110 - 114 - Broad-range inhibition of enterovirus replication by OSW-1, a natural compound targeting OSBP(2015)
Authors: Hendrik Jan Thibaut, Johan Neyts
Pages: 110 - 114 - Itraconazole Inhibits Enterovirus Replication by Targeting the Oxysterol-Binding Protein(2015)
Authors: Jeroen R P M Strating, Lonneke van der Linden, Lucian Albulescu, Joëlle Bigay, Minetaro Arita, Leen Delang, Pieter Leyssen, Hilde M van der Schaar, Kjerstin H W Lanke, Hendrik Jan Thibaut, et al.
Pages: 600 - 615 - Itraconazole Inhibits Enterovirus Replication by Targeting the Oxysterol-Binding Protein(2015)
Authors: Leen Delang, Pieter Leyssen, Hendrik Jan Thibaut, Johan Neyts
Pages: 600 - 615 - H1PVAT is a novel and potent early-stage inhibitor of poliovirus replication that targets VP1(2014)
Authors: Aloys Tijsma, Hendrik Jan Thibaut, Armando De Palma, Mohamed Koukni, Arnaud Marchand, Patrick Chaltin, Johan Neyts, Pieter Leyssen
Pages: 1 - 9 - Molecular biology and inhibitors of hepatitis A virus(2014)
Authors: Yannick Debing, Johan Neyts, Hendrik Jan Thibaut
Pages: 895 - 917 - Binding of glutathione to enterovirus capsids is essential for virion morphogenesis(2014)
Authors: Hendrik Jan Thibaut, Johan Neyts
Patents
1 - 10 of 10
- Coronavirus vaccines (Inventor)
- Novel compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient (Inventor)
- 1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient (Inventor)
- Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases (Inventor)
- Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases (Inventor)
- Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient (Inventor)
- Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient (Inventor)
- 1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient (Inventor)
- 1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient (Inventor)
- Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases (Inventor)